GAOResultsCover
Latest Post

More complete data on PEPFAR results needed, says second GAO treatment report

The second of two reports from the U.S. Government Accountability Office reviewing HIV treatment efforts suppported by the President’s Emergency Plan For AIDS Relief concludes that incomplete information on the results of those efforts will interfere with accurately evaluating partner countries’ abilities to sustain treatment programs. The GAO also has produced a report on PEPFAR [...]

More »

Recent Posts

GAOCostCover

GAO report highlights complexities of analyzing PEPFAR treatment costs

With the groundwork for treatment provided through the President’s Emergency Plan For AIDS Relief having been laid in the first expensive years of country programs, with the purchases of generic antiretroviral drugs, and with economies of scale as the numbers of people enrolled in treatment increased, PEPFAR has reduced per patient treatment costs in recent [...]

More »
More Recent Posts »

Live Blog Archive

HIV

More complete data on PEPFAR results needed, says second GAO treatment report

The second of two reports from the U.S. Government Accountability Office reviewing HIV treatment efforts suppported by the President’s Emergency Plan For AIDS Relief concludes that incomplete information on the results of those efforts will interfere with accurately evaluating partner countries’ abilities to sustain treatment programs. The GAO also has produced a report on PEPFAR [...]

Tuberculosis

Report from Maputo: Snapshots of TB/HIV efforts in Zambia, Zimbabwe

Zambia:  TB Control Pilot generates recommendations In 2010 a Human Rights Watch report charged the Zambian prison system with severe overcrowding, gross human rights violations and conditions that perpetuate infectious diseases, notably tuberculosis. The report led to a partnership between the Centre for Infectious Disease Research in Zambia with funding from the President’s Emergency Plan [...]

Research & Development

HPTN Annual Meeting: Superinfection raises questions, offers insights

What would people living with HIV do differently if they knew that they could be infected again, with a new strain, that could complicate both their disease, and their treatment?